CD4 and Autoimmunity: Selective therapeutic manipulation of CD4+ Tregs in autoimmunity has long been an objective (51) and the above-mentioned study reported that the blockade of the JAK-STAT pathway can restore CD4+ Treg cells and increase the ratio of CD4+Treg/CD4+ effector T cells (17).